Real-time human respiration carbon dioxide measurement device for cardiorespiratory assessment by Singh, O. P. et al.
J. Breath Res. 12 (2018) 026003 https://doi.org/10.1088/1752-7163/aa8dbd
PAPER
Real-time human respiration carbon dioxidemeasurement device
for cardiorespiratory assessment
OmPrakash Singh1, TeoAikHowe2 andMBMalarvili1
1 Bio-signal Processing ResearchGroup (BSPRG), Faculty of Biosciences andMedical Engineering, Universiti TeknologiMalaysia (UTM),
81310 Skudai, Johor Bahru, Johor,Malaysia
2 EmergencyDepartment,Hospital Pulau Pinang, Pinang,Malaysia
E-mail: bioom85@yahoo.com
Keywords: infraredCO2 sensor, ArduinoMega2560, TFT, cardiorespiratory, reliability, validation, evaluation
Supplementarymaterial for this article is available online
Abstract
The development of a human respiration carbon dioxide (CO2)measurement device to evaluate
cardiorespiratory status inside and outside a hospital setting has proven to be a challenging area of
research over the few last decades. Hence, we report a real-time, user operable CO2measurement
device using an infraredCO2 sensor (ArduinoMega2560) and a thinﬁlm transistor (TFT, 3.5″),
incorporatedwith lowpass (cut-off frequency, 10Hz) andmoving average (span, 8) ﬁlters. The
proposed devicemeasures features such as partial end-tidal carbon dioxide (EtCO2), respiratory rate
(RR), inspired carbon dioxide (ICO2), and a newly proposed feature—Hjorth activity—that annotates
datawith the date and time from a real-time clock, and is stored onto a secure digital (SD) card.
Further, it was tested on 22 healthy subjects and the performance (reliability, validity and relationship)
of each featurewas established using (1) an intraclass correlation coefﬁcient (ICC), (2) standard
errormeasurement (SEM), (3) smallest detectable difference (SDD), (4)Bland–Altman plot, and
(5)Pearson’s correlation (r). The SEM, SDD, and ICC values for inter- and intra-rater reliability were
less than 5%andmore than 0.8, respectively. Further, the Bland–Altman plot demonstrates thatmean
differences±standard deviations for a set limit were 0.30±0.77mmHg,−0.34±1.41mmHg and
0.21±0.64 breath perminute (bpm) for CO2, EtCO2 andRR. Theﬁndings revealed that the
developed device is highly reliable, providing validmeasurements for CO2, EtCO2, ICO2 andRR, and
can be used in clinical settings for cardiorespiratory assessment. This research also demonstrates that
EtCO2 andRR (r,−0.696) are negatively correlatedwhile EtCO2 and activity (r, 0.846) are positively
correlated. Thus, simultaneousmeasurement of these featuresmay possibly assist physicians in
understanding the subject’s cardiopulmonary status. In future, the proposed device will be testedwith
asthmatic patients for use as an early screening tool outside a hospital setting.
1. Introduction
Human respiration carbon dioxide (CO2) contains
signiﬁcant information that can assist physicians in
identifying spot ventilation derangements, extubation
outcomes, bronchospasm and the effectiveness of
therapy in the operating room, neonate intensive care
units, intensive care units (ICU), critical care units
(CCU) and in the clinical environment [1–3]. Further,
features extracted from CO2 signals, such as EtCO2,
respiratory rate (RR), time spent at EtCO2, exhalation
duration, Hjorth parameters (activity, mobility and
complexity), VCO2×slopeIII/RR, end-exhalation
slope, the slope ratio (SR), and area ratio can be used to
monitor and diagnose cardiopulmonary diseases, such
as chronic obstructive pulmonary disease (COPD),
asthma, congestive heart failure (CHF), pulmonary
embolism (PE), and pneumonia [4–12]. To date, to the
best our knowledge, the capnograph is the only device
on themarket that serves this purpose.
A capnograph is a non-invasive device that uses
infrared technology and measures human respiration
CO2 from expired gases and an incessant plot of
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capnogram signal looks like a square wave; a complete
two-breath cycle from a 2 min recording of a capno-
gram signal is displayed in ﬁgure 1. Each breath cycle
has four phases and two angles (see ﬁgure 1). ‘PQ’,
‘QR’, ‘RS’, and ‘ST’ indicate the expiration, alveolar,
the beginning of inspiration, and latency phase,
respectively, whereas both angles (α and β) represent
transitions between PQ, QR, and RS. Further, ‘R’ sig-
niﬁes the utmost value of CO2 at the end of the breath
that is designated as EtCO2 [13–15].
However, these features have not been incorpo-
rated into capnography in a clinical setting as the ﬁnd-
ings are performed in an ofﬂine mode. Besides,
capnography is bulky and expensive, and provides a
poor estimation of the ventilation and perfusion (V/Q)
status of the lung [16]. Therefore, there is an urgent
need for a lightweight, inexpensive, precise, and quanti-
tative CO2 measurement device. Hence, in this paper,
we propose a real-time human respiration CO2 mea-
surement device that can be used for cardiorespiratory
assessment in a user friendly environment. In order to
develop the proposed device, there are some important
points to consider: namely, CO2 features, existing tech-
nology, and a proper CO2 sensor. These points are dis-
cussed indetail in the subsequent sections.
1.1. Signiﬁcance of CO2 features
Over the past few decades, many studies have been
conducted on the extraction of capnogram features in
association with heart–lung diseases [7–12, 17–26]. Of
these, the study documented by Yaron et al [17] in
1996 investigated a parameter (alveolar slope) and
measured the slope (dCO2/dt) for ﬁve consecutive
expired breaths among 18 asthmatic subjects. They
concluded that the slope of the plateau of the
capnogram varies from 0.27±0.05–0.19±0.07 for
asthmatic patients during pre- and post medication.
Since then, it has become increasingly apparent that
the capnogram provides a new way to monitor the
inﬂammatory status in cardiorespiratory disorders.
Later, Guthrie et al [18] employed a microcap plus
device (Oridion Capnograph, Israel) for the measure-
ment of EtCO2 on16 asthmatic patients, and suggested
that non-invasive bedside measurement of EtCO2 is
feasible among children suffering from acute asthma.
Further, Nagurka et al [19] studied the changes in
extreme (both low and high) EtCO2 on 299 asthmatic
patients and recommended that initial EtCO2 mea-
surements may be a biomarker for asthmatic condi-
tions outside a hospital setting. Further, Kesten et al
[9] examined the RR correlation between 47 acutely ill
asthmatic patients and 42 non-asthmatic patients.
They concluded that RR increases during an asthma
attack, which coincides with the ﬁndings of Kassabian
et al [20] and Azab et al [21]. However, further studies
are required to determine the feasibility of EtCO2 and
RR for the early detection of asthma episodes beyond a
clinical assessment.
In addition, Howe et al [22] investigated four fea-
tures (the α-angle and slope of three different phases
of a capnogram) in connection with asthma using
Novametrix® capnometry among 30 asthmatic
patients. The ﬁndings revealed that the slope of the
phase III and α-angle can be used as indices to moni-
tor asthmatic conditions. To support these ﬁnding,
Kean et al [11] and Hisamuddin et al [23] both
advocated considering the slope of the phase III and
α-angle as indices for the diagnosis of asthma. In addi-
tion, Kean et al [11] also introduced new indices
(Hjorth parameters, SR, area ratio) to identify asth-
matic conditions. They concluded that the SR and the
newly introduced Hjorth parameters (HP2—mobi-
lity) were the best parameters to discriminate between
asthma and non-asthma. Further, Mieloszyk et al [10]
explored four physiological parameters (exhalation
duration, maximum CO2, time spent at maximum
CO2, and end-exhalation slope) from 30 healthy,
56 COPD, and 53 CHF subjects using a capnogram
signal, and correlated their ﬁndings with COPD versus
CHF and COPD versus normal subjects. The results
were statistically signiﬁcant with a receiver operating
characteristic curve of 0.89 for COPD/CHF classiﬁca-
tion, and 0.98 for COPD/healthy classiﬁcation. So far,
most studies have been carried out ofﬂine for the
extraction and analysis of the capnogram’s features
showing a strong correlation with obstructive lung
diseases. Hence, the incorporation, implementation,
and feasibility of these features while developing a real-
time human respiration CO2 measurement device are
yet to be veriﬁed. This motivated us to develop a real-
time, quantitative human respiration CO2 measure-
ment device with the disclosed features.
1.2. Available technology for the development of the
CO2measurement device
The side- and mainstream techniques are used for the
development of the CO2 measurement device as a
Figure 1.Expiration, alveolar plateau, and inspiration
phases of a capnogram signal. P: the onset of expiration; PQ
segment:mixture of dead space and alveolar gases; QR
segment: plateau phase showing alveolar gas delivery; RL:
indicates the end of expiration; RS segment: initiation of
inspiration; ST: lowCO2 concentration in the airway during
the remainder of inspiration.
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function of time or volume, as illustrated in
ﬁgures 2(a) and (b). In the sidestream technique, a
CO2 sensor is placed inside the main unit, away from
the subject, to detect the CO2molecules. Amini pump
aspirates the sample from the sampling tube at a
sampling rate of 50–200 ml min−1 which ensures the
sidestream capnograph is reliable for both adults and
children [10]. Hence, the sidestream technique has
been found to be more convenient, simple and easy to
sterilize compared with the mainstream technique. In
addition, it can be used when a patient is in an unusual
position [27, 28].
In contrast to the sidestream technique, a CO2 sen-
sor is placed between the endotracheal tube and the
breathing circuit in the mainstream method. Hence it
does not require a sampling tube, pump, motor, and
scavenges. In addition, themainstream capnograph has
a faster response time, a simple mechanism and amore
accurate sampling rate.However,mainstreamCO2 sen-
sors are relatively expensive, heavy and require solid
state sources, improved optics, and miniaturization
[29]. Furthermore, the mainstream CO2 sensor is
heated above body temperature, about 40 °C, in order
to prevent water vapor condensation, which may burn
the patient’s skin [29, 30]. Hence, we considered devel-
oping a time-based sidestream real-time CO2measure-
ment device based on a non-dispersive infrared (NDIR)
CO2 sensor, which is considered to be the predominant
form in ahospital setting [10].
1.3. Selection of infraredCO2 sensor
Over the last few years, many NDIR CO2 sensors, such
as Sprint IR [3, 31],MG811 [32], COZIR [33], COMET
[34], and MH410 [35], have been explored for the
development of a respiration CO2 measurement
device. Of these, COMET is considered as the most
suitable sensor due to its unique speciﬁcations (warm-
up time, response time, weight, and output), as
presented in table 1.
Table 1 illustrates that the warm-up time, response
time, weight, and output range of the COMET CO2
sensor is 2–15 s, 0.028 s,<7 g and 0%–13.8%, respec-
tively. These speciﬁcations indicate that the COMET
CO2 sensor is highly selective and sensitive to CO2 gas
compared to other sensors.
In addition, the sampling rate (100 samples per s)
of the COMET is comparatively high and provides
more precise and detailed analysis of the CO2 signal.
Hence, our developed CO2 measurement device uses
an NDIR CO2 sensor equivalent to COMET [36] to
acquire the CO2 signal. The NDIR sensor absorbs the
CO2molecules at a speciﬁc wavelength (4.3 μm) in the
infrared region and follows Beer–Lambert law, as
given in equation (1) [37–39]. This avoids any recom-
pense when different concentrations ofN2O,O2, anes-
thetic agents, and water vapor are present in the
inspired and expired breath:
= a- ( )I I e 1bt0
where I represents the intensity of the light hit on the
detector (Wcm−2), I0 is the considered intensity of the
empty chamber (W cm−2), α is the absorption
coefﬁcient (cm2 mol−1), b is the concentration of CO2
(cm2 mol−1), and t is the length of the absorption
path (cm).
Thus, for the ﬁrst time, we report a real-time, and
highly reliable human respiration CO2 measurement
device with the incorporation of a ﬁrst order low-pass
ﬁlter with a cut-off frequency (fc=10 Hz) and amov-
ing average ﬁlter (span, 8). In this paper, the complete
research work is organized as follows. In section 2, we
explain the technical details of the components used in
our research study, followed by the computation and
transmission processing algorithm, which includes
feature extraction, the noise reduction method, and
CO2 data display as presented in the supplementary
information (available online at stacks.iop.org/JBR/
12/026003/mmedia). In section 3, we report the data
Figure 2.CO2measurement technology: (a) sidestream, and (b)mainstream.
Table 1.Comparison of the speciﬁcations of variousNDIRCO2









Sprint IR <60 0.05 8 [3, 31]
MG811 300 <60 60 [32]
COZIR <10 4–120 20 [33]
COMET 2–15 0.028 <7.0 [34]
MH410 90 <30 20 [35]
s=second.
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collection and recording procedures along with the
statistical method used for the performance (reliability
and relationship) evaluation of the device. In section 4,
we present our results, followed by a discussion of the
signiﬁcance of the retrieved features, signal processing
techniques, and performance of the developed device
in section 5. Finally, in section 6, we conclude and out-
line the directions for future research in this area.
2.Material andmethods
2.1.Overview of the human respirationCO2
measurement device
Figure 3 shows a block diagram of the CO2 measure-
ment device. The device is comprised of four parts,
namely a CO2 acquisition unit, processing unit, real-
time control (RTC) and a display unit. The CO2 signal
is acquired from the subjects through a sampling tube
and is passed to a microcontroller unit for computa-
tion and transmission purposes. Further, the CO2
signal and other parameters (EtCO2, RR, ICO2, and
activity) are extracted and displayed on a thin ﬁlm
transistor (TFT) through serial communication. With
this, EtCO2 reﬂects the maximum CO2 concentration
of alveoli emptying last, RR is the rate at which
breathing occurs, ICO2 represents the amount of CO2
concentration inhalation during breathing that pro-
vides information regarding the rebreathing of CO2
which is caused due to an improper breathing circuit
setup or a patient’s unusual conditions, and activity is
the ﬁrst Hjorth’s parameter that measures the mean
power of each breath signal. The analysis considered
the slopes of the curve, which shows a strong correla-
tionwith the CO2 signal. The calculation of the activity
is based on variance, hence the computational cost of
this method is low compared to other methods. In
addition, data logging on an SD card is performed
through an RTC which is controlled by a processing
unit. The technical details of the components are
explained in the supplementary information. In addi-
tion, the feature extraction and display processes of the
CO2 signal are presented in the supplementary infor-
mation. Thereafter, the device performance is evalu-
ated using statisticalmethods.
3. Performance evaluation of the proposed
device
3.1.Data collection and recording procedures
In this study, a total of 22 healthy participants
aged between 21 and 35, (12 females, 23.85±4.02;
10 males, 29.81±3.75) were recruited from the
Faculty of Biosciences and Medical Engineering, Uni-
versiti Teknologi Malaysia (UTM) using random
sampling [40], and the characteristic details of the
participants are presented in table 2. An informed
consent was obtained from all the participants before
participating in the study. The data are presented in
mean±SDunless otherwise speciﬁed.
All the participants were asked to sit comfortably
in a chair with a backrest for 10 min and advised not to
participate in strong physical activity to avoid any
alteration in the EtCO2, RR and activity values, as pre-
sented in ﬁgures 4(a) and 5(b), respectively. Then, the
participants were instructed to breathe in and out
through the nasal cannula in a normal, relaxed man-
ner at their own pace. All the data (EtCO2, RR, ICO2
and activity) were recorded simultaneously for 2 min
[41]. To check the reliability and validity of the devel-
oped device further, statisticalmethodswere used.
Figure 3.Block diagramof the respirationCO2measurement device; CO2 acquisition unit (nasal cannula, water trap, pump,motor
andNDIRCO2 sensor), processing unit (AtMega2560 and arduino IDE), display unit (3.5″), displays (CO2 signal,Hjorth parameter,
EtCO2, ICO2 andRR), real-time control unit, and secure digital card (8GB).
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3.2. Statisticalmethod for performance (reliability
and validity) analysis
A repeated measures design was adopted to examine
the inter- and intra-rater reliability of the device for a
CO2 signal, EtCO2, RR, and activity. The reliability
studies were carried out by certiﬁed researchers of the
Good Clinical Practice on different occasions in
compliance with the UTM Health Center’s ethical
clearance standard. Reliability analysis helps to con-
ﬁrm whether the output is consistent or not when the
test is performed by the same or different users with
dissimilar times. In addition, it is believed that a device
cannot be valid until it is reliable [42]. Hence, in this
study, we have examined both the reliability and
validity of the newly developed device. To test the
validity, data were recorded using a standard
capnograph device (CapnostreamTM20 Model
CS08798) and the developed respiration CO2 mea-
surement device for each subject for 2 min.
For this, descriptive statistics (mean and standard
deviation) of the CO2 signal, EtCO2, RR, and Hjorth’s
parameter (activity) were calculated for all partici-
pants, both male and female. Further, the normality
distribution of each feature was analyzed with respect
to each measurement. For this, the skewness and kur-
tosis, z-values and Shapiro–Wilk p-values were calcu-
lated for a dependent variable to verify the normality
of the data for both males and females. The z-value
(−1.96<=z<=1.96) and Shapiro–Wilk p-value
(p>0.05) were considered statistically signiﬁcant
[43–47].
Further, the intraclass correlation coefﬁcient
(ICC) and its 95% conﬁdence interval (CI) were used
to quantify the inter- and intra-rater reliability. In
addition, to verify the level of absolute reliability and
sensitivity, SEM and SDD were calculated using
equations (2) and (3), respectively [48, 49]. The con-
vention of Rosner was adopted to describe the strength
of the ICCs (ICC<0.40=poor reliability;
0.40ICC<0.75=fair to good reliability, and
ICC0.75=excellent reliability) [50, 51]. Further,
the outputs of both devices were compared using
Bland–Altman analysis and the acceptable limit was
set at ±10% for CO2, EtCO2, and RR values, respec-
tively [52]. Additionally, the Pearson correlation coef-
ﬁcient was calculated to determine the relationship
between the features. Statistical analysis was per-
formed using SPSS (SPSS 23.0 for Windows) and the
signiﬁcance was set at p<0.05. The results are pre-
sented in section 4:
= ´ -( ) ( )SEM SD 1 ICC , 2
= ´ ´ ( )SDD 1.96 2 SEM, 3
where, SD is the standard deviation and ICC repre-
sents the intraclass correlation coefﬁcient value.
4. Result
4.1. Real-time human respirationCO2measurement
device
We report a real-time quantitative and user-operable
human respiration CO2measurement device based on
Table 2.Characteristic details of healthy subjects (n=22)presented by age and gender.
Age (Y) Weight (Kg) Height (m) BMI (Kg m−2)
Age Gender (n) X SD X SD X SD X SD
20–29 M (4) 25.75 2.75 72.75 9.91 1.68 0.03 25.67 3.20
F (12) 22.58 1.97 55.89 8.93 1.56 0.06 22.87 3.26
30–35 M (5) 31.80 2.48 76.00 16.83 1.72 0.07 25.56 5.37
F (1) 30.00 0.00 75.00 0.00 1.5 0.00 33.33 0.00
F= female,M=male, X=mean, SD= standard deviation, BMI= bodymass index, Y=years,m=meter.
Figure 4.The subjects’ posture during the experiment:
(a) (F, age 22), and (b) (M, age 30). The nasal cannulawas
attached into the nose to acquire and transport theCO2 signal
through the sampling tube (length: 7 feet).
Figure 5.Complete set-up of the device (preliminarymodel),
assembledwith a few components, such as a nasal cannula,
water trap, naﬁon tube, CO2 sensor,motor, pump, Arduino
Mega2560, switch, RTCmodule and display (TFT, 3.5″).
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sidestream technology that can be used inside and
outside a hospital setting. In addition, LPF (fc, 10) and
MAF (span, 8)were employed in order to reduce noise
and to provide a smooth CO2 signal. This helped in
extracting speciﬁc and precise features from the CO2
signal. A preliminary model (the internal arrangement
of components) of the device is presented in ﬁgure 5.
In this preliminary study, we preferred to extract
EtCO2, RR, ICO2, and the Hjorth parameter (activity)
due to the unfussiness and ease of implementation of
the algorithm (see the supplementary information)
and displayed all the parameters onto the TFT along
with the CO2 signal. These parameters (EtCO2, RR,
and ICO2) were exhibited for each breath whereas
Hjorth’s parameter (activity) was measured for every
breath and the mean of two consecutive breaths was
displayed. With this, EtCO2 reveals the maximum
amount of CO2 which exits the alveolus and increases
during a blockage in the air track when the subjects do
not adequately eject CO2 during expiration, RR dis-
plays the breathing pattern that may increase or
decrease depending on the subject’s severity of gasping
efﬁciency, and ICO2 reveals the rebreathing of CO2
gas. Figures 6(a) and (b) indicate the ideal and active
state, respectively, of the display where the horizontal
axis denotes the time, ranging from 0–20 s, and the
vertical axis indicates expired CO2, ranging from
0–80 mmHg.
Figure 6(a) shows the retrieved features and the
CO2 signal to be zero (‘0’), as the nasal cannula was not
subjected to testing. Figure 6(b) shows the CO2 signal
and associated features for a healthy subject (e.g.
EtCO2, 39.20 mmHg; RR, 15 bpm; ICO2, 0.00 and
activity, 2.30) as soon as the sample line is fastened.
There was a sweep in the CO2 signal after 19.98 s due
to a loss of 0.02 s when starting from the beginning.
Additionally, the obtained parameters and CO2 signal
were saved onto an SD card (8 GB) through an RTC
unit (DS3231), as presented in ﬁgure 7.With this, each
data point was saved inside a folder with respect to
date, day, and time with a delay of 10 ms, providing an
easy method of accessing the subject’s information in
the future. The code for each folder has a designated
ID containing the current date. In this, the saving pro-
cedure was controlled by a mechanical switch that
saves the data. With every press, a new ﬁle was gener-
ated according to the hour, minute, and second of the
day, depending upon the need of the subject or obser-
ver. Further, we have discussed the performance of the
ﬁlter and device in subsequent sections.
4.2. Implementation ofﬁlters
A 10 Hz FIR low-pass ﬁlter was applied to limit the
bandwidth and remove the upper-frequency compo-
nents of the CO2 signal. Figure 8(a) shows raw (red
dash line) and ﬁltered (blue dot point) CO2 signals.
This clearly shows that CO2 signals fall within 10 Hz. A
further moving average ﬁlter (span, 8) was applied to
provide smooth CO2 signals in order to avoid any
imprecision while extracting the features. In addition,
it also removed random noise while preserving the
sharp step response, making it the foremost, optimal
ﬁlter for a time domain programmed signal.
Figure 8(b) shows the raw (red line) and smoothed
CO2 signal (blue line) for ﬁve consecutive breaths,
extracted from a 2min recorded signal. The raw CO2
signal seems to be noisy, disturbed and has an irregular
shape that may provide an inaccurate result, whereas
the ﬁltered signal appears very smooth and crisp, with
regular shapes and a resolution of more than 99.10%
of the rawCO2 signal.
In addition, the correlation coefﬁcient was calcu-
lated for each CO2 signal after ﬁltering (low pass and
moving average) for a justiﬁed cut-off frequency and
span width, respectively. For example, the correlation
coefﬁcient for one of the subject’s signals after a low
Figure 6. (a)The ideal, and (b) active state of display of theCO2 signal and associated features. (Avideo for thisﬁgure is available online
at stacks.iop.org/JBR/12/026003/mmedia.)
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pass and moving average ﬁlter was 1.000 and
0.9910672, respectively.
4.3. Performance evaluation (reliability and
validity)
Further, the developed device was tested on 22 healthy
subjects, in order to ascertain the reliability, validity and
relationship of each feature. The recording procedures
have been explicated in section 3. The result revealed
that the mean and SD values of EtCO2, RR and activity
were 39.57±2.91mmHg, 17.00±2.33 bpm, and
1.69±0.45, respectively, whereas the ICO2 was
0.00 mmHg for all the healthy subjects, as presented in
ﬁgure 9. Further, the normality distribution of the data
was veriﬁed using skewness and kurtosis, z-values and
Shapiro–Wilk p-values. Our ﬁndings demonstrate that
each feature shows little skewness and kurtosis for both
males and females, but it does not differ signiﬁcantly
from normality. Hence, we assume that our data are
approximately normally distributed in terms of skew-
ness and kurtosis. Besides, Shapiro–Wilk p-values are
found above 0.05 for each feature for both males and
females. Therefore, we maintained a null hypothesis,
and in terms of the Shapiro–Wilk test, we assume that
data are approximately normally distributed. Thus, the
inter- and intra-rater reliability test was assessed based
on ICC, SEM and SDD, and the validity was assessed
using Bland–Altman plot analysis, whereas a relation-
ship was established using Pearson correlation coefﬁ-
cients (r).
4.3.1. Reliability analysis
The inter- and intra-rater reliability test was con-
ducted on two dissimilar occasions by two observers.
The ICC values (95% CI), SEM and SDD of inter- and
intra-rater reliability for all the parameters are sum-
marized in tables 3 and 4, respectively.
In our study, for inter-rater reliability, the ICC
ranged from 0.88–0.96 with an average (95% CI
0.83–0.97); SEM and SDD values ranged from
0.23–1.80 and 0.65–4.99, respectively. For intra-rater
reliability, the obtained ICC ranged from 0.78–0.96
with an average (95% CI 0.72–0.95); SEM and SDD
values ranged from 0.38–1.58 and 1.07–4.39, respec-
tively. The obtained ICC values for both reliabilities
were greater than 0.8, except the activity (intra-rater
ICC, 0.783) which revealed that the developed device
is highly reliable for all the measured parameters. In
addition, the SDD and SEM values were found to be
lower than 5% for all themeasured parameters, reveal-
ing the high level of absolute reliability and sensitivity,
i.e.measurement error was low and accuracy was high.
Therefore, one or more observers can use the device
and its features for the measurement of a CO2 signal
with little variation, demonstrating the device’s ease
of use.
4.3.2. Validation of the device and its features
The precision of the device was veriﬁed using a
Bland–Altman plot by comparing data obtained from
the developed device and standard capnography
(CapnostreamTM20 model CS08798). Figures 10(a)
and (b), 11(a) and (b) and 12(a) and (b) show Bland–
Altman plots, generated for CO2, EtCO2, and RR
measurements respectively. The plots display a data
point for each subject, where the x-coordinate is the
average of the two device measurements and the
y-coordinate is the difference between the measure-
ments as a percentage of the average. The 95% limit of
agreement between the mean differences for CO2,
EtCO2 and RR from standard capnography and the
readings from our device were 1.8 mmHg and
−1.2 mmHg (9.03% and −6.09%), 2.42 mmHg
and−3.10 mmHg (6.24% and−7.99%) and 1.47 bpm
and −1.04 bpm (8.51% and −5.94%), respectively. It
also revealed that the mean differences from the actual
values are closer to zero with bias inaccuracy for CO2,
EtCO2, and RR, which were 0.30 mmHg (1.47%),
−0.34 mmHg (−0.87%) and 0.21 bpm (1.28%),
respectively. Thus, the robustness of the developed
device in measuring different parameter values (CO2,
EtCO2 and RR) with the same performance is guaran-
teed comparedwith standard capnography.
4.3.3. Relationship between EtCO2, RR, and activity
The reason for establishing this relationship is that the
study conducted by Kesten et al [9], Nagurka et al [19],
Kassabian et al [20], Azab et al [21], Guthrie et al [18],
Brown et al [7] and Kean et al [11], reported that
during asthmatic and CHF attacks, RR increases
whereas EtCO2 and Hjorth’s parameter (activity)
decreases. However, to the best of our knowledge, to
date, no study has been performed combining all these
parameters in correlation with cardiorespiratory con-
ditions due to a lack of evidence. Hence, to verify the
ﬁndings, we performed bivariate correlation analysis
between these parameters to assess the relationship
between EtCO2, RR, and activity. The relationship
between EtCO2, RR, and activity is shown in
ﬁgures 13(a), (b). Figure 13(a) shows that EtCO2 and
RR (r=−0.70,N=22 and p=0.000) are negatively
Figure 7.Data (CO2, activity, EtCO2, ICO2, RR) loggingwith
date, day, and time.
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correlated. The ﬁgure shows a simple scatter regres-
sion graph which reveals that as EtCO2 increases, RR
tends to decrease, and the data points are in line with
the regression line, revealing that both have a moder-
ately strong linear association. Figure 13(b) shows that
EtCO2 and activity (r=0.85,N=22 and p=0.000)
are positively correlated. EtCO2 and activity both
increase simultaneously. Additionally, the values of
EtCO2 and activity are very near the line, specifying a
strong linear relationship. Thus, the ﬁnding reveals
that there is a moderately strong relationship between
EtCO2, RR, and activity.Hence a concurrentmeasure-
ment of these parameters may possibly help health
care professionals to evaluate the patient’s cardiopul-
monary status.
5.Discussion
To date, no studies have reported the incorporation of
both a noise reduction algorithm and newly introduced
features in correlation with cardiopulmonary assess-
ment in real time. An earlier study presented a side-
stream capnograph which measured EtCO2, RR and a
capnogram. However, the device was complex and the
computation cost was high due to the microcontroller
(AtMega 8535) and display (128×64), as the data
couldnot be saved [29]. Our developeddevicemeasures
the features EtCO2, RR, CO2 and the newly introduced
feature, activity, and is displayed on a high resolution
TFT (320×480). Additionally, it can save the data onto
Figure 8. (a)Original CO2 signal (red dash line) and low-passﬁltered (fc, 10 Hz)CO2 signal (blue dotted line), and (b) raw andmoving
average ﬁltered (smoothed)CO2 signal of a healthy subject.
Figure 9.Normality value of PetCO2, RR, and activity of
healthy subjects.
Table 3. Features extracted from theCO2 signal for a 2 min
recording and reliability test (n=22).
Features Inter-rater, ICC (95%CI) Intra-rater, ICC (95%CI)
PeCO2 0.957 (0.895–0.982) 0.920 (0.809–0.967)
EtCO2 0.963 (0.909–0.985) 0.968 (0.924–0.987)
RR 0.888 (0.732–0.953) 0.862 (0.673–0.942)
Activity 0.922 (0.810–0.968) 0.783 (0.484–0.909)
PeCO2= exhaled carbon dioxide; EtCO2= partial end-tidal
carbon dioxide; RR= respiratory rate; CI= conﬁdence interval;
ICC= intraclass correlation coefﬁcient; n= number of healthy
subjects.
Table 4.The standard error ofmeasurement
(SEM) is stated inmillimeters ofmercury
(mmHg) and breath perminute (bpm),
respectively for PeCO2, EtCO2, andRR. The
small detectable difference (SDD) is
dimensionless.
SEMand SDD (n= 22), respirationCO2mea-
surement device
Features Rater SEM SDD
PeCO2 Inter-rater 1.08 3.00
Intra-rater 1.42 3.94
EtCO2 Inter-rater 1.80 4.99
Intra-rater 1.58 4.39
RR Inter-rater 1.49 4.13
Intra-rater 1.54 4.28
Activity Inter-rater 0.23 0.65
Intra-rater 0.38 1.07
8
J. Breath Res. 12 (2018) 026003 OP Singh et al
an SD card via RTC which is mounted with a TFT. We
extracted these features in agreement with earlier
studies [9–11, 18–21, 53], since these can be used as
indiceswhen evaluating the cardiorespiratory condition
at a preliminary or extreme level. The research con-
ducted by Kesten et al [9], Azab et al [21], Guthrie et al
[18], Nagurka et al [19], Kean et al [11], Langhan et al
[53], and Lamba et al [8] suggested that the
Figure 10.Bland–Altman plots betweenmean and difference from standard capnogrpahy versusmeasured CO2 (a) inmmHg and
(b) in percentages. Dashed lines indicate the upper and lower 95% limits of agreement.
Figure 11.Bland–Altman plots between themean and difference from standard capnography versusmeasured EtCO2 (a) inmmHg
and (b) in percentages. Dashed lines indicate the upper and lower 95% limits of agreement.
Figure 12.Bland–Altman plots betweenmean and difference from standard capnography versusmeasured RR (a) in bpm and (b) in
per cent. Dashed lines indicate the upper and lowerwith 95% limits of agreement.
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measurement of these parameters can help observers to
evaluate the obstruction level in the air passage of
patients. Kean et al also reported that the computation
of a new feature (activity) for one breath is capable of
discriminating asthmatic and non-asthmatic condi-
tions with an AUC (0.8951) and p-value (<0.0001).
Further we veriﬁed the normality range of each feature
based on earlier studies, and ﬁndings revealed that the
datawere in thenormal range [53, 54].
Further, a noise reduction algorithm (LPF and
MAF) was implemented in real time in order to
smooth the shape of the CO2 signal, helping to extract
precise features. LPF was applied in agreement with an
earlier study to limit the bandwidth of the signal [55].
The application of two earlier advised 13-span ﬁlters
for MAF [10, 25, 56] to smooth the signal was tested,
and a loss of data ofmore than 4.9%was found. Hence
in our study we apply an optimum span 8 for high
resolution (99.1%) compared with previous studies.
Further, the consistency of each feature was veriﬁed
based on relative and absolute reliability analysis
[48, 57].
The relative reliability indicates the amount of any
changes in the measurement of healthy subjects in
each feature measurement, and clariﬁes, by actual dif-
ferences, the true value of the attribute being quanti-
ﬁed. We found that the ICC value for the inter-rater
test was 0.88–0.96; this demonstrates that 88%–96%
of the quantity deviation was due to inconsistency in
the true value of the measured attribute and 12%–4%
to random inter-subject variability. For the intra-rate
test, ICC was 0.78–0.96; this demonstrates that the
78%–96% measurement difference was owing to the
changeability in the true value of the measured
characteristic, and 22%–4% to chance in the intra-
subject variability. Since ICC values ofmore than 0.7%
are acceptable in clinical settings, the developed device
may provide useful information for diagnostic and
classiﬁcation purposes in cardiopulmonary patients.
In the absolute analysis, the SEM provides an
approximation of the error size of each feature and
indicates the absolute reliability [48], whereas SDD
reveals the sensitivity of the changes in the measured
value [48]. Both the SEM and SDD values collectively
disclose a change in the index, reﬂecting the reliability
of the indicators [58]. The lower SEM and SDD
demonstrate the greater reliability in the accuracy and
precision of the measured values. Further, when the
SEM value is less than 10% of the average measured or
the highest measured score, the quantify error is small,
and thus the measurement is reliable [58]. We found
that SEM and SDD activity was 0.38% and 1.07%
respectively for the intra-rater test, but 0.23% and
0.65% for the inter-rater test compared with other fea-
tures with less than 5%. Thus, the ﬁndings reveal that
68% of the repeat measurements are likely to fall
within +1.80 (maximum, SEM) of the true value for
each parameter, in agreement with earlier studies
[59, 60]. Further, the precision of the developed device
is discussed by comparing the output with standard
capnography (CapnostreamTM20 Model CS08798)
fromOridion.
From ﬁgures 10(a) and (b), 11(a) and (b) and 12(a)
and (b), it can be seen that some outliers are observed
in the CO2 and EtCO2 measurements; however, most
of the data points fall within the limits of agreement. In
addition, SD values were found close to each other
with an average value of approximately 5%.
Figure 13.Relationships: (a)EtCO2 versus RR, and (b)EtCO2 versus activity.
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Accordingly, the difference between the measure-
ments of the device for any subject is supposed to be
±10% relative to the bias. Thus, these results show
that the differences between both devices measure-
ments are within an acceptable range. Hence, the
Bland–Altman plots reveal a reasonable consistency
between themeasurements of the developed and exist-
ing capnography device. Thus, the developed device is
capable of providing valid and robust measurements.
Hence, it is considered to be a valid monitoring device
that can be used as an alternative to a standard capno-
graphy device for clinical and home monitoring pur-
poses. Further, a relationship was established using
Pearson’s coefﬁcient as a proof of hypothesis regard-
ing the correlation between EtCO2, RR and activity
during obstructive lung diseases [9, 61].
We found that EtCO2 and RR are negatively corre-
lated with (r=−0.7); this reveals that there is a 70%
chance of an increase in the RR value during the initial
stage of a blockage in the wind pipe, and EtCO2 values
decrease, which concurs with the statement from
Kesten et al [9], and English [61]. Additionally, EtCO2
and activity are positively correlated with (r=0.85)
each other and have an 85% probability of an increase
in activity with an increase in EtCO2 values. Hence
concurrent measurement of these parameters possibly
may help health care professionals to evaluate the
patient’s cardiopulmonary status. In the next section,
the strengths and limitations of the device are
discussed.
5.1.Device strengths and limitations
The developed device is small in size (12.50 cm×
13 cm×8 cm), light weight (650 g) and user operable.
Hence it can be used by health care professionals in
their work place setting, as well as in emergency
settings, unlike traditional capnography, in order to
evaluate the cardiorespiratory condition. Further, it
can be used by individuals who have been affected by
cardiorespiratory disorders in their home or work
place, and data can be recorded and sent to health
professionals via a simple mail transfer protocol.
Further, it does not require any special skills or
training in order to operate the device, in contrast to
existing devices.
In addition, the developed device is incorporated
with a noise reduction algorithm that eliminates ran-
dom noise while preserving the sharp step response
during CO2 data recording, unlike existing devices.
Another novel feature of the device is that it estimates
Hjorth’s parameter (activity) from each breath cycle
considering the slope of the CO2 signal; hence it may
be useful for providing obstructive lung disease infor-
mation, in contrast to existing capnography. In addi-
tion, capnography is not only used in ICU to conﬁrm
endotracheal intubation, assessment of cardiac out-
put, and the detection of gastric tubes inadvertently
placed in the trachea, but it can also be used to identify
and assess obstructive lung diseases such as COPD,
asthma, and CHF because of changes in the character-
istics of the CO2 waveform. Further, existing capno-
graphy devices only measure the maximum and
minimum amount of CO2 and RR from each breath
cycle, which does not involve an analysis of the slope of
the resultant CO2 signal and is unable to provide clear
information about the ventilation and perfusion status
of the lung. Hence, the incorporation of these features
are an added advantage thatmay be useful in recogniz-
ing and assessing cardiorespiratory status more efﬁ-
ciently compared with existing devices. On the other
hand, the developed device has limitations which war-
rant caution. The device only saves the measured fea-
tures (CO2, EtCO2, RR, ICO2, and activity) but cannot
transfer data to remotely located physicians providing
care to a patient either in hospital or elsewhere.
Finally, the atmosphere pressure and temperature
values should be set as per the location in the sketch to
avoid false respiration CO2 readings while using the
sensor.
6. Conclusion and futurework
We developed a non-invasive, highly reliable, precise,
and user operable real-time human respiration CO2
measurement device based on sidestream technology
that measures expired CO2. The developed device
displays the quantiﬁed features such as EtCO2, RR,
ICO2, activity, and CO2 signal on a small and single
screen (TFT), hence minimizing the size of the device.
In addition, this is the ﬁrst device which has been
incorporated with low-pass (fc, 10 Hz) and moving
average ﬁlters (span, 8) after signal conversion (ana-
log-to-digital) that reduces the total computation cost
and provides a sharp and smooth CO2 signal. The
developed device has been tested successfully on 22
subjects in order to ascertain the reliability, validity
and relationship of the features. The ﬁndings revealed
that the inter- and intra-rater mean of each parameter
was more than 0.75 and mean differences±standard
deviations for a set limit were 0.30±0.77 mmHg,
−0.34±1.41 mmHg and 0.21±0.64 bpm for CO2,
EtCO2 and RR, which demonstrate that the developed
device can be used in a clinical setting. The developed
device also enabled frequent measurements of the
features over a continuous period of time, and
delivered accurate and reproducible readings that are
not limited by inter- or intra-observer variability. We
also found that the features are strongly correlated,
and concurrent measurements may assist the physi-
cian in assessing cardiopulmonary conditions. In the
future, a performance evaluation of the developed
device will be carried out on asthma patients.
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